High-level EGFR expression (EGFR immunointensity of 2+ or 3+) was observed in only 2.0% (1 out of 52) of the analysed cervical adenocarcinomas/adenosquamous cell carcinomas (Figure 1B). Here, EGFR is linked to cervical adenocarcinoma.